On March 8, 2024, Ovid Therapeutics (NASDAQ: OVID) released its Q4 earnings report, revealing some key points from the announcement:
– Earnings: Ovid Therapeutics fell short of estimated earnings by -340.0%, with an EPS of $-0.22 compared to the expected $-0.05.
– Revenue: The company saw a $95 thousand increase in revenue compared to the same period last year.
– Past Performance: In the previous quarter, Ovid Therapeutics surpassed EPS expectations by $0.03, resulting in a 1.0% increase in share price the following day.
For more in-depth financial information and quarterly results, you can check out Ovid Therapeutics’ Investor Relations page.
OVID Therapeutics (OVID) Stock Sees Slight Decline on March 8, 2024 – Investors Keep Watch for Price Changes
On March 8, 2024, OVID Therapeutics (OVID) experienced a slight decline in its stock performance. The stock closed at $3.17, which was $0.08 lower than the previous market close. This represents a 2.46% drop in the stock price.
Despite the drop in price during regular trading hours, OVID’s stock remained unchanged in after-hours trading. This suggests that there was no significant movement in the stock price after the market closed.
Overall, OVID’s performance on March 8th was relatively stable, with a slight decline in the stock price but no major fluctuations in after-hours trading. Investors will continue to monitor the stock’s performance in the coming days to see if there are any significant changes in price momentum.
OVID Stock Performance Analysis: Revenue Declines but EPS Shows Improvement
On March 8, 2024, OVID stock experienced a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $1.50 million for the past year, which represents a significant decrease of 99.28% compared to the previous year. However, there was a positive increase of 45.3% in total revenue since the last quarter. In terms of net income, OVID reported a net loss of $54.17 million for the past year, indicating a decrease of 145.2% compared to the previous year. However, there was a slight improvement in net income with a decrease of 9.32% since the last quarter. Earnings per share (EPS) for OVID stock was reported at -$0.77 for the past year, reflecting a decrease of 143.31% compared to the previous year. On a positive note, there was an increase of 9.44% in EPS since the last quarter. Overall, the financial performance of OVID stock on March 8, 2024, showed a mix of positive and negative trends. Investors and analysts will closely monitor these financial indicators to assess the company’s future growth prospects and stock performance.
